Damora Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DMRA and other ETFs, options, and stocks.About DMRA
Damora Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2.
DMRA Key Statistics
Stock Snapshot
The current Damora Therapeutics(DMRA) stock price is $26.70, with a market capitalization of 1.61B. The stock trades at a price-to-earnings (P/E) ratio of -5.82.
On 2026-04-20, Damora Therapeutics(DMRA) stock moved within a range of $26.45 to $28.54. With shares now at $26.70, the stock is trading +0.9% above its intraday low and -6.4% below the session's peak.
Trading activity shows a volume of 22.25K, compared to an average daily volume of 287.34K.
The stock's 52-week range extends from a low of $2.36 to a high of $38.33.
The stock's 52-week range extends from a low of $2.36 to a high of $38.33.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.